BMY vs L · P/E 17, rev $24.46B vs P/E 14, rev $18.45B
Bristol-Myers Squibb Company (BMY) versus Loews Corp (L) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Loews Corp (L) is a insurance - property & casualty company listed on NYSE.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported L revenue for 2025-12-31 was $18.45B. Net income was $1.67B. Revenue was up 5.4% from 2024-12-31 to 2025-12-31. L currently screens at market cap $22.36B and trailing P/E 13.8.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. L currently screens at market cap $22.36B and trailing P/E 13.8.
Not investment advice. Open the BMY and L stock pages for the full models.
Not investment advice.